Activation of CaMKII in diabetes is driven by multiple post-translational modifications, including O-GlcNAcylation (i.e., the O-linked attachment of β-N-acetylglucosamine to Ser/Thr residues), oxidation and S-nitrosylation (reviewed in [139]). The gene discussed is CAMK2G; the disease is diabetes mellitus.